[HTML][HTML] Covid-19: virology, variants, and vaccines
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
[HTML][HTML] Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
WG Dos Santos - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract Coronavirus disease 19 (COVID-19) continues to challenge most scientists in the
search of an effective way to either prevent infection or to avoid spreading of the disease. As …
search of an effective way to either prevent infection or to avoid spreading of the disease. As …
[HTML][HTML] A review of SARS-CoV-2 variants and vaccines: viral properties, mutations, vaccine efficacy, and safety
MA Islam - Infectious Medicine, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus
disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all …
disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all …
[HTML][HTML] COVID-19 vaccines: Current evidence and considerations
A Tavilani, E Abbasi, FK Ara, A Darini, Z Asefy - Metabolism open, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with
devastating health, business and social impacts. Vaccination is a safe, simple, and effective …
devastating health, business and social impacts. Vaccination is a safe, simple, and effective …
The end or a New Era of development of SARS-CoV-2 virus: Genetic variants responsible for severe COVID-19 and clinical efficacy of the most commonly used …
Although the chief of the World Health Organization (WHO) has declared the end of the
coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a …
coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a …
[HTML][HTML] The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
JA Malik, S Ahmed, A Mir, M Shinde, O Bender… - Journal of infection and …, 2022 - Elsevier
Abstract Background The SARS-CoV-2 coronavirus epidemic is hastening the discovery of
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …
COVID-19 vaccines: current conditions and future prospects
T Zieneldien, J Kim, J Cao, C Cao - Biology, 2021 - mdpi.com
Simple Summary The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first encountered in …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first encountered in …
Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy
The widespread increase in multiple severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) variants is causing a significant health concern in the United States and …
(SARS-CoV-2) variants is causing a significant health concern in the United States and …
Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants
in different continents is causing a major concern in human global health. These variants …
in different continents is causing a major concern in human global health. These variants …
The biological and clinical significance of emerging SARS-CoV-2 variants
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel
spike protein mutations that are influencing the epidemiological and clinical aspects of the …
spike protein mutations that are influencing the epidemiological and clinical aspects of the …